Early studies have reported that TOX is a tumor cell-specific marker of CTCLs including early MF based on immunohistochemical findings, as it is expressed in tumor cells of cutaneous T-cell lymphomas (CTCLs) but barely in inflammatory infiltrate of BIDs (16). The gene discussed is TOX; the disease is neoplasm.